查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1492526

截肢后慢性疼痛管理市场：按类型、治疗类型、最终用户划分 - 全球预测 2024-2030

Chronic Post-Amputation Pain Management Market by Type (Neuroma Pain, Phantom Limb Pain, Stump Pain), Treatment Type (Medication, Neuromodulation Techniques, Surgical Interventions), End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

截肢后慢性疼痛管理市场规模预计到 2023 年为 56.5 亿美元，2024 年达到 59.6 亿美元，2030 年达到 83.1 亿美元，预计复合年增长率为 5.66%。

慢性截肢后疼痛是指一些人在肢体或部分肢体截肢后所经历的持续性疼痛。这种类型的疼痛可以有多种形式，包括幻肢痛（在缺失的肢体中感觉到疼痛）和残肢疼痛（在截肢的残肢中感觉到疼痛）。由此产生的不适可能是中度至重度，使日常生活变得困难，并可能导致情绪和心理困扰。这种疼痛管理需要结合药物治疗、物理治疗，有时还需要心理咨询，以解决截肢对身体和心理的影响。主要由于糖尿病、血管疾病和创伤导致的截肢数量不断增加，导致对有效的截肢后疼痛管理解决方案的需求不断增长。许多地区支持医疗保健服务的政府政策和报销框架涵盖了慢性疼痛管理治疗，使患者更容易获得治疗，并进一步支持市场扩张。然而，与用于治疗慢性截肢后疼痛的医疗产品的开发和处置相关的环境问题正在阻碍市场成长。脊髓刺激和周边神经刺激等神经调节技术可以帮助控制截肢后的慢性疼痛。研究和开发侵入性较小且更易于使用的更复杂的神经调节设备为截肢后慢性疼痛管理市场的成长提供了重大机会。

主要市场统计
基准年[2023] 56.5亿美元
预测年份 [2024] 59.6亿美元
预测年份 [2030] 83.1亿美元
复合年增长率（%） 5.66%

区域洞察

在美洲，特别是在美国和加拿大，人们非常关注先进的药物治疗和技术主导的解决方案来管理慢性截肢后疼痛。此外，在疼痛讯号到达大脑之前对其进行调节的神经调节剂的使用以及义肢对准和组装服务越来越注重减少因义肢适配不良引起的不适。在亚太地区，由于医疗保健成本不断上升、人们对疼痛管理解决方案的认识不断提高以及医疗保健基础设施的改善，用于治疗全关节重建术后慢性疼痛的截肢后慢性疼痛管理市场正在不断发展。日本和澳洲等国家拥有先进的医疗设施，并愿意采用新技术和治疗方法。在欧洲、中东和非洲地区，特别是欧洲，先进的医疗设备和强大的法律规范支持截肢后疼痛管理的综合方法。中东国家，特别是沙乌地阿拉伯和阿拉伯联合大公国等海湾国家，正在迅速发展医疗基础设施，并增加获得最新疼痛管理疗法的机会。在非洲，人们逐渐意识到需要更好的疼痛管理策略，医疗保健服务也逐渐改善。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在慢性截肢后疼痛管理市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对慢性截肢后疼痛管理市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对截肢后慢性疼痛管理市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高对疼痛管理方法的认识并改善医疗基础设施
      • 人们对药物和非药物疼痛管理疗法越来越感兴趣。
      • 政府支持政策和医疗报销
    • 抑制因素
      • 治疗方案成本高
    • 机会
      • 神经调节技术的不断进步
      • 需要以患者为中心的医疗保健模式，强调个人化治疗计划
    • 任务
      • 专业医护人员短缺、药物副作用等问题
  • 市场区隔分析
    • 类型：对幻肢痛管理以缓解疼痛和提高生活品质的需求不断增长
    • 最终用途：医院截肢后慢性疼痛管理的需求不断增加
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章截肢后慢性疼痛管理市场：依类型

  • 神经瘤疼痛
  • 幻肢痛
  • 切面疼痛

第七章依治疗类型分類的截肢后慢性疼痛管理市场

  • 药物治疗
  • 神经调节技术
  • 手术治疗
  • 治疗

第八章截肢后慢性疼痛管理市场：依最终用途分类

  • 居家护理
  • 医院
  • 疼痛诊所
  • 復健中心

第九章美洲截肢后慢性疼痛管理市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区截肢后慢性疼痛管理市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲截肢后慢性疼痛管理市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Trinity Capital 投资 Neuros Medical 以加强截肢者的疼痛管理
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-99555D550529

[180 Pages Report] The Chronic Post-Amputation Pain Management Market size was estimated at USD 5.65 billion in 2023 and expected to reach USD 5.96 billion in 2024, at a CAGR 5.66% to reach USD 8.31 billion by 2030.

Chronic post-amputation pain refers to the ongoing pain that some individuals experience after having a limb or part of a limb amputated. This type of pain manifests in various forms, including phantom limb pain, where the person feels pain in the part of the limb that is no longer there, and residual limb pain, which is pain in the stump of the amputated limb. The arising discomfort can be moderate to severe and might affect the individual's quality of life, making it difficult to perform daily activities and potentially leading to emotional or psychological distress. Managing this pain requires a combination of medical treatments, physical therapy, and sometimes psychological counseling to address the physical and emotional effects of amputation. A rise in the number of amputations primarily due to diabetes, vascular diseases, and traumatic injuries contributes to a greater demand for effective post-amputation pain management solutions. Government policies supporting healthcare services and reimbursement frameworks in many regions cover treatments for chronic pain management, making treatments more accessible to patients and further propelling market expansion. However, environmental concerns associated with developing and disposing of medical products for managing chronic post-amputation pain hinder market growth. Neuromodulation techniques, such as spinal cord and peripheral nerve stimulation, help manage chronic post-amputation pain. The research and development in more sophisticated neuromodulation devices that are less invasive and more user-friendly offer significant opportunities for chronic post-amputation pain management market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 5.65 billion
Estimated Year [2024] USD 5.96 billion
Forecast Year [2030] USD 8.31 billion
CAGR (%) 5.66%

Regional Insights

In the Americas, particularly in the United States and Canada, there is a strong focus on advanced medicinal treatments and technology-driven solutions for managing chronic post-amputation pain. In addition, there is a growing emphasis on using neuromodulation devices, which help modulate pain signals before they reach the brain, and prosthetic alignment and fitting services reduce the discomfort caused by poorly fitted prostheses. In the Asia-Pacific region, the chronic post-amputation pain management market for managing chronic post-amputation pain is evolving, driven by increasing healthcare expenditure, growing awareness about pain management solutions, and an improved healthcare infrastructure. Countries, including Japan and Australia, feature advanced medical facilities and readily adopt new technologies and treatments. In the EMEA region, particularly In Europe, the availability of advanced healthcare facilities and a strong regulatory framework support a comprehensive approach to post-amputation pain management. Middle Eastern countries, particularly Gulf states such as Saudi Arabia and the UAE, are rapidly improving their healthcare infrastructure and have increasing access to modern pain management therapies. In Africa, there is an increasing recognition of the need for better pain management strategies, leading to gradual improvements in healthcare offerings.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Chronic Post-Amputation Pain Management Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising awareness of pain management options and better healthcare infrastructure
      • Increasing preference for pharmacological and non-pharmacological pain management therapies
      • Supportive government policies and healthcare reimbursement
    • Market Restraints
      • High cost of treatment options
    • Market Opportunities
      • Ongoing advancements in neuromodulation technologies
      • Need for patient-centric healthcare models emphasizing personalized treatment plans
    • Market Challenges
      • Limited availability of specialized medical professionals and issues associated with medication side effects
  • Market Segmentation Analysis
    • Type: Increasing demand for phantom limb pain management to enhance quality of life by relieving pain
    • End-Use: Growing need for chronic post-amputation pain management in hospitals
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Chronic Post-Amputation Pain Management Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Chronic Post-Amputation Pain Management Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Trinity Capital Invested in Neuros Medical to Enhance Pain Management for Amputees

Trinity Capital Inc. committed a USD 25 million investment to Neuros Medical, Inc. This infusion of capital aims to advance Neuros Medical's innovative bioelectric technology, which is dedicated to reducing chronic pain for individuals who have undergone amputations, improving their quality of life. [Published On: 2023-10-31]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Chronic Post-Amputation Pain Management Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Chronic Post-Amputation Pain Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Arm Dynamics, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, ATI Physical Therapy, B. Braun Melsungen AG, Einstein Healthcare Network, GlaxoSmithKline PLC, Memorial Healthcare System, Novartis AG, Pfizer Inc., Physiopedia, Propel Physiotherapy, Select Medical Corporation, Smart Solutions Rehab Group, Teva Pharmaceutical Industries Ltd., and The Rehabilitation Hospital of Montana.

Market Segmentation & Coverage

This research report categorizes the Chronic Post-Amputation Pain Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Neuroma Pain
    • Phantom Limb Pain
    • Stump Pain
  • Treatment Type
    • Medication
    • Neuromodulation Techniques
    • Surgical Interventions
    • Therapy
      • Mirror Therapy
      • Physical Therapy
      • Psychological Therapy
  • End-Use
    • Home Care
    • Hospitals
    • Pain Clinics
    • Rehabilitation Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness of pain management options and better healthcare infrastructure
      • 5.1.1.2. Increasing preference for pharmacological and non-pharmacological pain management therapies
      • 5.1.1.3. Supportive government policies and healthcare reimbursement
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment options
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in neuromodulation technologies
      • 5.1.3.2. Need for patient-centric healthcare models emphasizing personalized treatment plans
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of specialized medical professionals and issues associated with medication side effects
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing demand for phantom limb pain management to enhance quality of life by relieving pain
    • 5.2.2. End-Use: Growing need for chronic post-amputation pain management in hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Chronic Post-Amputation Pain Management Market, by Type

  • 6.1. Introduction
  • 6.2. Neuroma Pain
  • 6.3. Phantom Limb Pain
  • 6.4. Stump Pain

7. Chronic Post-Amputation Pain Management Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Medication
  • 7.3. Neuromodulation Techniques
  • 7.4. Surgical Interventions
  • 7.5. Therapy

8. Chronic Post-Amputation Pain Management Market, by End-Use

  • 8.1. Introduction
  • 8.2. Home Care
  • 8.3. Hospitals
  • 8.4. Pain Clinics
  • 8.5. Rehabilitation Centers

9. Americas Chronic Post-Amputation Pain Management Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Chronic Post-Amputation Pain Management Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Chronic Post-Amputation Pain Management Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Trinity Capital Invested in Neuros Medical to Enhance Pain Management for Amputees
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET DYNAMICS
  • FIGURE 7. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMA PAIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMA PAIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHANTOM LIMB PAIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHANTOM LIMB PAIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STUMP PAIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STUMP PAIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMODULATION TECHNIQUES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMODULATION TECHNIQUES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY SURGICAL INTERVENTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY SURGICAL INTERVENTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MIRROR THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MIRROR THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PSYCHOLOGICAL THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PSYCHOLOGICAL THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PAIN CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
  • TABLE 296. PO